Skip to content

Thymosin Alpha-1

Emerging evidence

Immunomodulatory peptide derived from thymus; research in immune function and infection. Not medical advice; consult a provider.

How Thymosin Alpha-1 works

Thymosin alpha-1 may regulate T-cell function and cytokine balance. Use only with a healthcare provider; not for self-directed immune boosting.

Researched benefits

  • •Immune modulation in research
  • •Support in some infectious and immune conditions
  • •May enhance vaccine response in studies

What it is studied for

  • •Immune support in research
  • •Chronic infection and immune dysregulation in clinical contexts
  • •Often used under specialist care

Reported side effects and cautions

  • •Generally well tolerated
  • •Contraindicated in certain autoimmune and transplant settings

Dosing protocol described in the literature

Dosage
Per provider
Frequency
As prescribed
Administration
Subcutaneous
Cycle
Per provider

Immune modulation

Work out the reconstitution for this dose →

Evidence rating: Emerging evidence

Some human data exists but the evidence base is limited — often small studies, narrow indications, or trials still under way.

Other peptides

BPC157TB500 (Thymosin B4 Acetate)Semaglutide (Ozempic / Wegovy)Tirzepatide (GLP-1/GIP dual agonist)CagrilintideRetatrutide + Cagrilintide (combination)

See every peptide in the library →

Educational information only. This page is not medical advice, not a prescription, and not a recommendation to use Thymosin Alpha-1. Dosing figures describe what appears in published research and provider protocols — they are not instructions. Several compounds covered here are prescription medicines. Talk to a licensed healthcare provider before acting on anything you read.